Founder Of Biotech Firm Caris Life Sciences Becomes A Billionaire After IPO
The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion.| Forbes
A former intelligence operative in Israel’s military warned of Iran’s cyber capabilities. But the U.S.’s cyber agency may struggle to respond.| Thomas Fox-Brewster
The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion.| Forbes
In this week’s edition of InnovationRx, we look at the dangers of RFK Jr.’s vaccine advisory committee, how Trump’s visa ban bars foreign doctors, the first FDA-approved transcontinental telesurgery, and more.| Forbes
In this week’s edition of InnovationRx, we look at RFK Jr.’s vaccine advisory committee purge, a tech billionaire’s funding of research on AI and healthcare, Omada’s IPO and more.| Forbes
